Navigation Links
Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
Date:5/6/2008

gic goals, drug development plans, results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre- clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, which will be filed with the SEC on or about May 8, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
2. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
3. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
4. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
5. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
6. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
7. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 Research and Markets ... Chinese Medical X-ray Film Industry Report 2014" report ... Global And Chinese Medical X-Ray Film ... on the current state of the Global medical X-ray ... The report provides a basic overview of the ...
(Date:7/11/2014)... , July 11, 2014  Kindred Hospital Houston ... announce the opening of its new outpatient wound ... services to people with chronic, hard to heal ... can lead to amputation, lower leg wounds related ... delayed closure, and traumatic injury wounds which are ...
(Date:7/11/2014)... York , July 11, 2014 ... Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative ... Share, Growth, Trends and Forecast, 2013-2019" the global endoscopy ... 2012 and is expected to grow at a CAGR ... estimated value of USD 36.9 billion in 2019. ...
Breaking Medicine Technology:Global and Chinese Medical X-ray Film Industry Report 2014 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... Dynatronics Corporation (NASDAQ: DYNT ) plans to ... March 31, 2012 during the morning of Tuesday, May 15, ... for investors later that day at 3:30 p.m. ET to ... Those interested in participating should call (800) 676-3536. ...
... Rogosin Institute (Rogosin) and the Hebrew Home at Riverdale ... and nephrology medical management for the residents and rehabilitation ... residents and patients of Hebrew Home will have peritoneal ... Hebrew Home are both members of NewYork Presbyterian Healthcare ...
Cached Medicine Technology:The Rogosin Institute and Hebrew Home Collaborate to Provide New Dialysis Service for Residents and Patients 2
(Date:7/11/2014)... to a new market research report “Internet of Things ... Bluetooth, Wi-Fi, NFC, RFID), Application Vertical (Building Automation, Consumer, ... - Global Trends & Forecasts to 2014 - 2020”, ... $1029.5 Billion in 2013, and is expected to reach ... 4.08% from 2014 to 2020. , Browse more ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 As reported ... and FiercePharma (Weintraub 7/11/14), a significant number of severe ... sugar, abdominal issues and even death from the highly-promoted ... According to the Times report , a regulatory ... 2013 reported by patients was almost 14% of prescriptions, ...
(Date:7/11/2014)... NY (PRWEB) July 11, 2014 The ... the five years to 2014 on the heels of ... 2010 prompted farmers to dedicate a larger share of ... production. More specifically, the regulations required the mixing of ... expanding biofuel production in the United States created a ...
(Date:7/11/2014)... 2014 Ticket Down is a reliable source for ... View, CA. Over the years Luke Bryan has been honored ... does he do well at award shows, but each summer, he ... anticipated tours of the genre and this summer is more of ... compare to the popularity and success that is currently entitled to ...
(Date:7/11/2014)... July 11, 2014 Europe is one ... to large cultivated-and hence, irrigated land area. The agricultural ... Europe, accounting for around 30.0% of the total water ... greater in the southern region, but far from negligible ... irrigation accounts for over 60.0% of the water use ...
Breaking Medicine News(10 mins):Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 2Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 3
... YWCA USA Annual General Assembly elected new officers and members of ... its recent 2009 National Conference in Washington, D.C.New officers include:, ... Debra Stock, Executive Director of YWCA York, Pennsylvania , ... Director of YWCA Greater Chicago, Illinois , ...
... Empire State Building,s lights to glow red in honor ... 14 , 12 Noon - 12:15 P.M. ... YORK, May 12 Gay Men,s Health Crisis (GMHC) ... the Empire State Building,s famed floodlights will soon honor ...
... A new study has sounded the alarm that ... lifespan and don,t exercise enough during their leisure time. ... and Physical Activity , the study is unique in ... 1981 Canada Fitness Survey, the 1988 Campbell,s Survey of ...
... coalition of health and human rights activists held simultaneous events in New ... release of two Iranian physicians imprisoned since June. , ... New York, ... and a coalition of health and human rights activists held simultaneous events ...
... Joseph,s Hospital and Medical Center, Phoenix, today announced the ... Inc. for the deployment of the company,s ... system will be used to connect specialist physicians at ... This program will include the Barrow Neurological Institute, as ...
... key in improving Alzheimer,s research , , TUESDAY, May 12 ... cerebrospinal fluid may help predict the rate of cognitive ... information could be used to improve the effectiveness of ... in the May issue of the journal Archives ...
Cached Medicine News:Health News:YWCA USA Elects New National Leadership 2Health News:Hilary Duff to Light Empire State Building Commemorating 24th Annual AIDS Walk New York 2Health News:Hilary Duff to Light Empire State Building Commemorating 24th Annual AIDS Walk New York 3Health News:22-year study finds adults aren't active enough 2Health News:Physicians for Human Rights and 20 Countries Demand Iran Release AIDS Doctors 2Health News:Physicians for Human Rights and 20 Countries Demand Iran Release AIDS Doctors 3Health News:St. Joseph's Hospital and Medical Center Signs Agreement for Innovative Video Conferencing Use 2Health News:Biomarkers May Help Measure Rate of Decline in Dementia 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: